Shelley D. Spray - 25 May 2023 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Reporting relationship: Director
Issuer ticker: PLSE
Reported as of: 25 May 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Jun 2023, 19:30:02 UTC
Prior SEC filing: 23 May 2022
Source filing: View source filing
Reporting owner signature: /s/ Kenneth B. Stratton, as Attorney-in-Fact

Key filing fact

Shelley D. Spray filed Form 4 for Pulse Biosciences, Inc. (PLSE) on 06 Jun 2023.

Key facts

This page summarizes Shelley D. Spray's Form 4 filing for Pulse Biosciences, Inc. (PLSE).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 06 Jun 2023, 19:30.

Change

Previous filing in this sequence was filed on 23 May 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PLSE transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +20,000
Change %
Price: $0.000000
Shares after: 20,000
Date: 25 May 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 20,000
Exercise price: $5.95
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on June 25, 2023.